Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular effects of esmolol alone and in combination with levosimendan during septic shock
2012-003012-31Phase 2Active
- Sponsor
- French Defence Health Service
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of esmolol, levosimendan in septic shock, sponsored by French Defence Health Service. Started Sep 2015; status: active.
02
Drugs
esmolollevosimendan
03
Conditions
septic shock
Beyond the preview
Go deeper on 2012-003012-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003012-31.